The sodium iodide symporter: Its pathophysiological and therapeutic implications

Clinical Endocrinology

Volumn 57, Issue 5, 2002, Pages 559-574

  Spitzweg, Christine ^a   Morris, John C ^b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER;

ACTIVE TRANSPORT; BIOACCUMULATION; ECTOPIC THYROID GLAND; LACTATION; MAMMARY GLAND; MEDICAL RESEARCH; MOLECULAR CLONING; NONHUMAN; OVARY FOLLICLE CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; THYROID DISEASE; THYROID FOLLICLE; THYROID GLAND; THYROID SCINTISCANNING;

EID: 0036425965     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01640.x     Document Type: Review

References (122)

1. Ajjan, R.A., Findlay, C., Metcalfe, R.A., Watson, P.F., Crisp, M., Ludgate, M. et al. (1998a) The modulation of the human sodium iodide symporter activity by Graves' disease sera. Journal of Clinical Endocrinology and Metabolism, 83, 1217-1221.
2. Ajjan, R.A., Kamaruddin, N.A., Crisp, M., Watson, P.F., Ludgate, M. & Weetman, A.P. (1998b) Regulation and tissue distribution of the human sodium iodide symporter gene. Clinical Endocrinology, 49, 517-523.
3. Ajjan, R.A., Watson, P.F., Findlay, C., Metcalfe, R.A., Crisp, M., Ludgate, M. et al. (1998c) The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. Journal of Endocrinology, 158, 351-358.
4. Ajjan, R.A., Kemp, E.H., Waterman, E., Watson, P., Endo, T., Onaya, T. et al. (2000) Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism, 85, 2020-2027.
5. Arturi, F., Russo, D., Schlumberger, M., Du Villard, J.-A., Caillou, B., Vigneri, P. et al. (1998) Iodide symporter gene expression in human thyroid tumors. Journal of Clinical Endocrinology and Metabolism, 83, 2493-2496.
6. Behr, M., Schmitt, T.L., Espinoza, C.R. & Loos, U. (1998) Cloning of a functional promoter of the human sodium/iodide symporter gene. Biochemical Journal, 331, 359-363.
7. Bidart, J.-M., Mian, C., Lazar, V., Russo, D., Filetti, S., Caillou, B. et al.(2000) Expression of pendrin and the pendred syndrome (PDS) gene in human thyroid tissues. Journal of Clinical Endocrinology and Metabolism, 85, 2028-2033.
8. Boland, A., Ricard, M., Opolon, P., Bidart, J.-M., Yeh, P., Filetti, S. et al. (2000) Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Research, 60, 3484-3492.
9. Boland, A., Magnon, C., Filetti, S., Bidart, J.-M., Schlumberger, M., Yeh, P. et al. (2002) Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers. Thyroid, 12, 19-26.
10. - symporter distribution in human thyroid tissues: An immunohistochemical study. Journal of Clinical Endocrinology and Metabolism, 83, 4102-4106.
11. Carlin, S., Cunningham, S.H., Boyd, M., McCluskey, A.G. & Mairs, R.J. (2000) Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two-and three-dimensional models. Cancer Gene Therapy, 7, 1529-1536.
12. Carrasco, N. (1993) Iodide transport in the thyroid gland. Biochemical et Biophysical Acta, 1154, 65-82.
13. Castro, M.R., Bergert, E.R., Beito, T.G., Roche, P.C., Ziesmer, S.C., Jhiang, S.M. et al. (1999a) Monoclonal antibodies against the human sodium iodide symporter: Utility for immunocytochemistry of thyroid cancer. Journal of Endocrinology, 163, 495-504.
14. Castro, M.R., Bergert, E.R., Beito, T.G., McIver, B.D., Goellner, J.R. & Morris, J.C. (1999b) Development of monoclonal antibodies against the human sodium iodide symporter: Immunohistochemical characterization of this protein in thyroid cells. Journal of Clinical Endocrinology and Metabolism, 84, 2957-2962.
15. Castro, M.R., Bergert, E.R., Goellner, J.R., Hay, I.D. & Morris, J.C. (2001) Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: Correlation with radioiodine uptake. Journal of Clinical Endocrinology and Metabolism, 86, 5627-5632.
16. Caturegli, P., Hejazi, M., Suzuki, K., Dohan, O., Carrasco, N., Kohn, L.D. et al. (2000) Hypothyroidism in transgenic mice expressing IFN-g in the thyroid. Proceedings of the National Academy of Sciences of the USA, 97, 1719-1724.
17. - symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid disease (AITD). Journal of Clinical Endocrinology and Metabolism, 85, 3937-3940.
18. - symporter expression in mammary glands. Journal of Clinical Endocrinology and Metabolism, 85, 2936-2943.
19. - symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Therapy, 7, 740-749.
20. Dadachova, E., Bouzahzah, B., Zuckier, L.S. & Pestell, R.G. (2002) Rhenium-188 as an alternative to iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS). Nuclear Medicine and Biology, 29, 13-18.
21. Dai, G., Levy, O. & Carrasco, N. (1996) Cloning and characterization of the thyroid iodide transporter. Nature, 379, 458-460.
22. - symporter (NIS) in a large sampling of thyroid cancer cases. Journal of Clinical Endocrinology and Metabolism, 86, 2697-2700.
23. Dumont, J.E., Jauniaux, J.C. & Roger, P.P. (1989) The cyclic AMP-mediated stimulation of cell proliferation. Trends in Biochemistry and Science, 14, 67-71.
24. Endo, T., Kaneshige, M., Nakazato, M., Kogai, T., Saito, T. & Onaya, T. (1996a) Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity. Biochemical and Biophysical Research Communications, 228, 199-202.
25. - symporter in the sera of patients with autoimmune thyroid disease. Biochemical and Biophysical Research Communications, 224, 92-95.
26. - symporter gene. Molecular Endocrinology, 11, 1747-1755.
27. Eng, P.H.K., Cardona, G.R., Fang, S.-L., Previti, M., Alex, S., Carrasco, N. et al. (1999) Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology, 140, 3404-3410.
28. Eskin, B.A. (1970) Iodine metabolism and breast cancer. Transactions of the New York Academy of Science, 32, 911-947.
29. Eskin, B., Bartuska, D., Dunn, M.R., Jacob, G. & Drafman, M.B. (1967) Mammary gland dysplasia in iodine deficiency. Journal of the American Medical Association, 200, 691.
30. Everett, L.A., Glaser, B., Beck, J.C., Idol, J.R., Buchs, A., Heyman, M. et al. (1997) Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nature Genetics, 17, 411-422.
31. - symporter. Nature Genetics, 16, 124-125.
32. - symporter in patients with iodide transport defect. Journal of Clinical Endocrinology and Metabolism, 83, 2940-2943.
33. Fujiwara, H., Tatsumi, K., Tanaka, S., Kimura, M., Nose, O. & Amino, N. (2000) A novel V59E missense mutation in the sodium iodide symporter gene in a familiy with iodide transport defect. Thyroid, 10, 471-474.
34. Funahashi, H., Imai, T., Tanaka, Y., Tobinaga, J., Wada, M., Morita, T. et al. (1996) Suppressive effect of iodine on DMBA induced breast tumour growth in the rat. Journal of Surgical Oncology, 61, 209-213.
35. Furlanetto, T.W., Nguyen, L.Q. & Jameson, J.L. (1999) Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology, 140, 5705-5711.
36. Garcia, B. & Santisteban, P. (2002) PI3K is involved in the IGF-1 inhibition of TSH-induced sodium/iodide symporter gene expression. Molecular Endocrinology, 16, 342-352.
37. Haberkorn, U., Henze, M., Altmann, A., Jiang, S., Morr, I., Mahmut, M. et al. (2001) Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. Journal of Nuclear Medicine, 42, 317-325.
38. Halmi, N.S. (1961) Thyroidal iodide transport. Vitamins and Hormones, 19, 133-163.
39. - symporter gene expression in rat thyroid FRTL-5 cells. Molecular and Cellular Endocrinology, 157, 31-39.
40. Huang, M., Batra, R.K., Kogai, T., Lin, Y.Q., Hershman, J.M., Lichtenstein, A. et al. (2001) Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Therapy, 8, 612-618.
41. - symporter in human thyroid tissues and salivary gland tissues. Endocrinology, 139, 4416-4419.
42. Joba, W., Spitzweg, C., Schriever, K. & Heufelder, A.E. (1999) Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases. Thyroid, 9, 455-466.
43. - symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells. Thyroid, 7, 789-794.
44. Kemp, E.H., Waterman, E.A., Ajjan, R.A., Smith, K.A., Watson, P.F., Ludgate, M.E. et al. (2001) Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease. Clinical and Experimental Immunology, 124, 377-385.
45. Kilbane, M., Ajjan, R., Weetman, A., Dwyer, R., McDermott, E., O'Hggins, N. et al. (2000) Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. Journal of Clinical Endocrinology and Metabolism, 85, 1245-1250.
46. Kitazono, M., Robey, R., Zhan, Z., Sarlis, N.J., Skarulis, M.C., Aikou, T. et al. (2001) Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(-) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. Journal of Clinical Endocrinology and Metabolism, 86, 3430-3435.
47. Kogai, T., Endo, T., Saito, T., Miyazaki, A., Kawaguchi, A. & Onaya, T. (1997) Regulation of thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology, 138, 2227-2232.
48. Kogai, T., Curcio, F., Hyman, S., Cornford, E.M., Brent, G.A. & Hershman, J.M. (2000a) Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. Journal of Endorinology, 167, 125-135.
49. Kogai, T., Schultz, J., Johnson, L., Huang, M. & Brent, G. (2000b) Retinoic acid induces sodium/iodide symporter gene expression and radio-iodine uptake in the MCF-7 breast cancer cell line. Proceedings of the National Academy of Sciences, USA, 97, 8519-8524.
50. Kogai, T., Hershman, J.M., Motomura, K., Endo, T., Onaya, T. & Brent, G.A. (2001) Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma lines and normal thyroid cells. Endocrinology, 142, 3369-3379.
51. Kopp, P. (1999) Pendred's syndrome: Identification of the genetic defect a century after its recognition. Thyroid, 9, 65-69.
52. Kosugi, S., Inoue, S., Matsuda, A. & Jhiang, S.M. (1998a) Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients. Journal of Clinical Endocrinology and Metabolism, 83, 3373-3376.
53. Kosugi, S., Sato, Y., Matsuda, A., Ohyama, Y., Fujieda, K., Hiroaki, I. et al. (1998b) High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures. and Metabolism, 83, 4123-4129.
54. Kosugi, S., Bhayana, S. & Dean, H.J. (1999) A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect. Journal of Clinical Endocrinology and Metabolism, 84, 3248-3253.
55. La Perle, K.M.D., Shen, D., Buckwalter, T.L.F., Williams, B., Haynam, A., Hinkle, G. et al. (2001) In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer. Prostate, 50, 170-178.
56. - symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes. Journal of Clinical Endocrinology and Metabolism, 84, 3228-3234.
57. - symporter with an anti-COOH terminus antibody. Proceedings of the National Academy of Sciences, USA, 94, 5568-5573.
58. - symporter (NIS): Recent advances. Journal of Bioenergetics and Biomembranes, 30, 195-206.
59. Lin, J.-D., Hsueh, C., Chao, T.-C. & Weng, H.-F. (2001) Expression of sodium iodide symporter in benign and malignant human thyroid tissue. Endocrine Pathology, 12, 15-20.
60. Mandell, R.B., Mandell, L.Z. & Link, C.J. (1999) Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Research, 59, 661-668.
61. Matsuda, A. & Kosugi, S. (1997) A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. Journal of Clinical Endocrinology and Metabolism, 82, 3966-3971.
62. Mazzaferri, E.L. (1996) Carcinoma of follicular epithelium: Radioiodine and other treatments and outcomes. In: The Thyroid: A Fundamental and Clinical Text, 7th edn (eds L.E. Braverman & R.D. Utiger), pp. 922-945. Lippincott-Raven, Philadelphia.
63. Mazzaferri, E.L. & Jhiang, S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418-428.
64. Min, J.-J., Chung, J.-K., Lee, Y.J., Jeong, J.M., Lee, D.S., Jang, J.J. et al. (2001) Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma. European Journal of Nuclear Medicine, 28, 639-645.
65. Moon, D.H., Lee, S.J., Park, K.Y., Park, K.K., Ahn, S.H., Pai, M.S. et al. (2001) Correlation between 99mTc-pertechnetate uptakes and expression of human sodium iodide symporter gene in breast tumor tissues. Nuclear Medicine and Biology, 28, 829-834.
66. Morris, J.C., Bergert, E.R. & Bryant, W.P. (1997) Binding of IgG from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: Evidence for the iodide transporter as an autoantigen. Thyroid, 7, 527-534.
67. - symporters for radioiodide concentrator gene therapy. Journal of Nuclear Medicine, 41, 1898-1904.
68. - symporter gene expression. Molecular Endocrinology, 12, 727-736.
69. Ohno, M., Zannini, M., Levy, O., Carrasco, N. & Di Lauro, R. (1999) The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic AMP-dependent transcription. Molecular and Cellular Biology, 19, 2051-2060.
70. Park, H.-J., Kim, J.Y., Park, K.Y., Gong, G., Hong, S.J. & Ahn, I.-M. (2000) Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid, 10, 211-217.
71. - symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology, 139, 703-712.
72. Perron, B., Rodriguez, A.-M., Leblanc, G. & Pourcher, T. (2001) Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. Journal of Endocrinology, 170, 185-196.
73. Pinke, L.A., Dean, D.S., Bergert, E.R., Spitzweg, C., Dutton, C.M. & Morris, J.C. (2001) Cloning of the mouse sodium iodide symporter. Thyroid, 11, 935-939.
74. Pohlenz, J. & Refetoff, S. (1999) Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism. Biochimie, 81, 469-476.
75. Pohlenz, J., Mederios-Neto, G., Gross, J.L., Silveiro, S.P., Knobel, M. & Refetoff, S. (1997) Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene. Biochemical and Biophysical Research Communications, 240, 488-491.
76. Pohlenz, J., Rosenthal, I.M., Weiss, R.E., Jhiang, S.M., Burant, C. & Refetoff, S. (1998) Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic-3′ splice site. Journal of Clinical Investigation, 101, 1028-1035.
77. Pohlenz, J., Duprez, L., Weiss, R., Vassart, G., Refetoff, S. & Costagliola, S. (2000) Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. Journal of Clinical Endocrinology and Metabolism, 85, 2366-2369.
78. - cotransporter as a potential autoantigen in thyroid autoimmune disease. European Journal of Endocrinology, 132, 399-405.
79. Riedel, C., Levy, O. & Carrasco, N. (2001) Post-transcriptional regulation of the sodium/iodide symporter (NIS) by thyrotropin. Journal of Biological Chemistry, 276, 21458-21463.
80. Rillema, J.A. & Yu, T.X. (1996) Prolactin stimulation of iodide uptake into mouse mammary gland explants. American Journal of Physiology, 271, E879-E882.
81. Rillema, J.A. & Rowady, D.L. (1997) Characteristics of the prolactin stimulation of iodide uptake into mouse mammary gland explants. Proceedings of the Society for Experimental Biology and Medicine, 215, 366-369.
82. Rillema, J.A., Yu, T.X. & Jhiang, S.M. (2000) Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants. American Journal of Physiological and Endocrinological Metabolism, 279, E769-E772.
83. Rillema, J.A., Williams, C.H., Moulden, J. & Golden, K.L. (2001) Effect of insulin on iodide uptake in mouse mammary gland explants. Experimental Biology in Medicine, 227, 32-35.
84. Ringel, M.D., Anderson, J., Souza, S.L., Burch, H.B., Tambascia, M., Shriver, C.D. et al. (2001) Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Modern Pathology, 14, 289-296.
85. Royaux, I., Suzuki, K., Mori, A., Katoh, R., Everett, L.A., Kohn, L.D. et al. (2000) Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology, 141, 839-845.
86. Russo, D., Bulotta, S., Bruno, R., Arturi, F., Giannasio, P., Derwahl, M. et al. (2001a) Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter. European Journal of Endocrinology, 145, 591-597.
87. Russo, D., Manole, D., Arturi, F., Suarez, H.G., Schlumberger, M., Filetti, S. et al. (2001b) Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas. Thyroid, 11, 37-39.
88. - symporter. Journal of Clinical Endocrinology and Metabolism, 83, 3247-3251.
89. - symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. Journal of Clinical Endocrinology and Metabolism, 82, 3331-3336.
90. Saito, T., Endo, T., Kawaguchi, A., Ikeda, M., Katoh, R., Kawaoi, A. et al. (1998) Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. Journal of Clinical Investigation, 101, 1296-1300.
91. Schmutzler, C., Winzer, R., Meissner-Weigl, J. & Kohrle, J. (1997) Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochemical and Biophysical Research Communications, 240, 832-838.
92. Schröder-van der Elst, J.P., van der Heide, D., Kastelijn, J., Rousset, B. & Obregon, M.J. (2001) The expression of the sodium/iodide symporter is up-regulated in the thyroid of fetuses of iodine-deficient rats. Endocrinology, 142, 3736-3741.
93. Scott, D.A., Wang, R., Kreman, T.M., Sheffield, V.C. & Karniski, L.P. (1999) The Pendred syndrome gene encodes a chloride-iodide transport protein. Nature Genetics, 21, 440-443.
94. - symporter in patients with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism, 85, 4630-4634.
95. - symporter gene. Endocrinology, 138, 4493-4496.
96. Simon, D., Koehrle, J., Reiners, C., Boerner, A.R., Schmutzler, C., Mainz, K. et al. (1998) Redifferentiation therapy with retinoids: Therapeutic option for advanced follicular and paillary carcinoma. World Journal of Surgery, 22, 569-574.
97. Smanik, P.A., Liu, Q., Furminger, T.L., Ryu, K., Xing, S., Mazzaferri, E.L. et al. (1996) Cloning of the human sodium iodide symporter. Biochemical and Biophysical Research Communications, 226, 339-345.
98. Smanik, P.A., Ryu, K.-Y., Theil, K.S., Mazzaferri, E.L. & Jhiang, S.M. (1997) Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology, 138, 3555-3558.
99. Smit, J.W.A., Schröder-van der Elst, J.P., Karperien, M., Que, I., van der Pluijm, G., Goslings, B. et al. (2000) Reestablishment ofvitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line. Thyroid, 10, 939-943.
100. 131I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line. Journal of Clinical Endocrinology and Metabolism, 87, 1247-1253.
101. Spitzweg, C., Joba, W., Eisenmenger, W. & Heufelder, A.E. (1998) Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. Journal of Clinical Endocrinology and Metabolism, 83, 1746-1751.
102. Spitzweg, C., Joba, W., Morris, J.C. & Heufelder, A.E. (1999a) Regulation of sodium-iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid, 9, 821-830.
103. Spitzweg, C., Joba, W., Schriever, K., Goellner, J.R., Morris, J.C. & Heufelder, A.E. (1999b) Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. Journal of Clinical Endocrinology and Metabolism, 84, 4178-4184.
104. Spitzweg, C., Zhang, S., Bergert, E.R., Castro, M.R., McIver, B.D., Tindall, D.J. et al. (1999c) Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Research, 59, 2136-2141.
105. Spitzweg, C., O'Connor, M.K., Bergert, E.R., Tindall, D.J., Young, C.Y.F. & Morris, J.C. (2000) Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Research, 60, 6526-6530.
106. Spitzweg, C., Dutton, C.M., Castro, M.R., Bergert, E.R., Goellner, J.R., Heufelder, A.E. et al. (2001) Expression of the sodium iodide symporter in human kidney. Kidney International, 59, 1013-1023.
107. Stanbury, J.B. & Dumont, J.E. (1983)Familial Goiter and Related Disorders, pp. 231-269. McGraw-Hill, New York.
108. Suzuki, K., Mori, A., Saito, J., Moriyama, E., Ullianich, L. & Kohn, L.D. (1999) Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Endocrinology, 140, 5422-5430.
109. Tatsumi, K.-I., Miyai, K. & Amino, N. (1998) Genetic basis of congenital hypothyroidism: Abnormalities in the TSHbgene, the PIT1 gene, and the NIS gene. Clinical Chemistry and Laboratory Medicine, 36, 659-662.
110. Tazebay, U.H., Wapnir, I.L., Levy, O., Dohan, O., Zuckier, L.S., Zhao, Q.H. et al. (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nature Medicine, 6, 871-878.
111. Tonacchera, M., Agretti, P., Ceccarini, G., Lenza, R., Refetoff, S., Santini, F. et al. (2001a) Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. European Journal of Endocrinology, 144, 611-618.
112. Tonacchera, M., Viacava, P., Agretti, P., De Marco, G., Perri, A., Di Cosmo, C. et al. (2001b) Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein. Journal of Clinical Endocrinology and Metabolism, 87, 352-357.
113. - symporter gene. Biochemical and Biophysical Research Communications, 239, 34-41.
114. Trapasso, F., Iuliano, R., Chiefari, E., Arturi, F., Stella, A., Filetti, S. et al. (1999) Iodide symporter gene expression in normal and transformed rat thyroid cells. European Journal of Endocrinology, 140, 447-451.
115. - symporter mRNAs in dog thyroid. Molecular and Cellular Endocrinology, 131, 195-203.
116. Valenta, L. (1966) Metastatic thyroid carcinoma in man concentrating iodide without organification. Journal of Clinical Endocrinology, 26, 1317-1324.
117. Venkataraman, G.M., Yatin, M. & Ain, K.B. (1998) Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50. Thyroid, 8, 63-69.
118. - symporter gene methylation status. Journal of Clinical Endocrinology and Metabolism, 84, 2449-2457.
119. Wolff, J. (1964) Transport of iodide and other anions in the thyroid gland. Physiological Review, 44, 45-90.
120. Wolff, J. & Chaikoff, I.L. (1948) Plasma inorganic iodide as a homeostatic regulator of thyroid function. Journal of Biological Chemistry, 174, 555-564.
121. Wolff, J., Chaikoff, I.L., Goldberg, R.C. & Meier, J.R. (1949) The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinology, 45, 504-513.
122. Xu, J., Kogai, T., Brent, G.A. & Hershman, J.M. (2002) A GC box in the human sodium iodide symporter gene promoter is essential for full activity. Thyroid, 12, 107-114.